Published by Benjamin Chiou on 2nd June 2025
(Sharecast News) - Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary listing to the Nasdaq.
URL: http://www.digitallook.com/dl/news/story/35119164/...